Artificial Intelligence in Genomics


Deeya1056

Uploaded on Oct 3, 2024

Category Technology

According to this latest publication from Meticulous Research®, the global AI in genomics market is slated to register a CAGR of 42.8% during the forecast period 2022–2029 to reach $6.22 billion by 2029

Category Technology

Comments

                     

Artificial Intelligence in Genomics

Artificial Intelligence in Genomics Market Worth $6.22 Billion by 2029 Global AI In Genomics Market - 2022 to 2029 The Artificial Intelligence in Genomics Market is expected to reach $6.22 billion by 2029, at a CAGR of 42.8% from 2022 to 2029. The Study of Genomics and Its Applications Genomics is the field of biology that deals with the analysis, sequencing, and mapping of genomes, the entire genetic material of an organism. AI is playing an increasingly pivotal role in genomics, particularly in areas like variant calling, genome annotation, and genetic diagnosis. These advancements are propelling the genomics sector forward, especially as more companies seek to apply this knowledge to drug discovery, diagnostics, and precision medicine. Technological innovations are further enhancing the accuracy, cost-effectiveness, and speed of genome mapping, driving interest and investment in this space. Download Sample Copy Here: https://www.meticulousresearch.com/download- sample-report/cp_id=5345 Widespread Impacts of Genomic Research The impact of genomic research reaches far beyond the healthcare sector. Fields such as biotechnology, agriculture, and social sciences are also benefiting from advances in genomics. With AI's growing presence, the complexity of genomic data is becoming more manageable. According to the National Human Genome Research Institute, genomic research could generate between 2 and 40 exabytes of data in the next ten years. As DNA sequencing techniques become more sophisticated, the need for AI- based tools to analyze and interpret this massive data influx becomes critical. AI Facilitating the Development of Precision Medicine AI tools are transforming genomic data into valuable clinical insights that can guide the development of targeted therapies. This allows for more precise treatment plans tailored to individual genetic profiles, making precision medicine a reality. With the rapid advancements in AI technologies, genomic data is now being © Meticulous Research| [email protected] Page 1 of 2 Global AI In Genomics Market - 2022 to 2029 used to create highly personalized therapies that improve patient outcomes across various medical conditions. Key Developments in AI-Powered Genomics Several companies are leading the way in integrating AI into genomics research, backed by significant funding. In March 2022, Illumina Accelerator supported startups working on breakthroughs in diagnostics and DNA storage. NonExomics is using AI to develop a platform that maps new drug targets from under- researched genomic regions. DNAnexus raised $200 million to expand its AI and machine learning-based genomics platform, while SeqOne Genomics raised $23.66 million for its AI- driven personalized genomic solutions. Additionally, Deep Genomics secured $180 million to enhance its AI therapeutics platform. Trending Blog : https://meticulousblog.org/the-growing-synergy-between-ai-and- genomics-revolutionizing-medicine-and-beyond Conclusion The synergy between AI and genomics is opening up new opportunities for innovation in healthcare and beyond. As investments continue to rise and AI technologies evolve, the global AI in genomics market is poised for tremendous growth, with projections indicating it will reach $6.22 billion by 2029. This growth highlights the potential of AI in revolutionizing genomics, particularly in the fields of drug discovery, diagnostics, and precision medicine. Key Players The key players operating in the global AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.). Quick Buy : https://www.meticulousresearch.com/Checkout/40485578 About Meticulous Research® Meticulous Research® is a leading provider of comprehensive market intelligence, offering actionable insights and analysis across various industries. Our reports empower businesses to make informed decisions, drive growth, and remain competitive in a rapidly evolving marketplace. Contact: Meticulous Market Research Pvt. Ltd. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- [email protected] Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research © Meticulous Research| [email protected] Page 2 of 2